Author： Ganesh Santhi K Skelding Kimberly A Mehta Laxmi O’Neill Kathleen Joo Jungnam Zheng Gang Goldstein James Simari Robert Billings Eric Geller Nancy L Holmes David O’Neill William W Nabel Elizabeth G
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.5, Iss.7, 2004-10, pp. : 949-1004
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Rosiglitazone reduces in-stent restenosis in patients with diabetes
Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. :
Access to resources
Recommend
Candesartan cilexetil may reduce in-stent restenosis
Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. :
High-dose valsartan for prevention of in-stent restenosis
Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. :
Sirolimus: In-stent restenosis in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1239, 2009-01 ,pp. :
Drug-eluting stents beat other therapies for in-stent restenosis
Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. :